Cervical Spinal Cord Magnetization Transfer Ratio and Its Relationship With Clinical Outcomes in Multiple Sclerosis.
Saved in:
| Title: | Cervical Spinal Cord Magnetization Transfer Ratio and Its Relationship With Clinical Outcomes in Multiple Sclerosis. |
|---|---|
| Authors: | Lee LE; Department of Medicine (Neurology), University of Toronto, Toronto, Ontario, Canada.; BARLO Multiple Sclerosis Centre, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.; Keenan Research Centre, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada., Cohen-Adad J; NeuroPoly Lab, Institute of Biomedical Engineering, Polytechnique Montréal, Montreal, QC, Canada.; Functional Neuroimaging Unit, CRIUGM, Montreal, QC, Canada.; Mila-Quebec AI Institute, Montreal, QC, Canada., Vavasour IM; Department of Radiology, University of British Columbia, Vancouver, B.C., Canada., Guenette M; BARLO Multiple Sclerosis Centre, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada., Sawicka K; Department of Medicine (Neurology), University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Child Health Evaluative Sciences Program, SickKids Research Institute, Toronto, Ontario, Canada., Rashidi-Ranjbar N; Keenan Research Centre, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada., Churchill N; Keenan Research Centre, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.; Department of Physics, Toronto Metropolitan University, Toronto, Ontario, Canada., Chopra A; Department of Medicine (Neurology), University of British Columbia, Vancouver, B.C., Canada., Adelia A; Department of Medicine (Neurology), University of British Columbia, Vancouver, B.C., Canada., Benveniste PL; NeuroPoly Lab, Institute of Biomedical Engineering, Polytechnique Montréal, Montreal, QC, Canada.; Mila-Quebec AI Institute, Montreal, QC, Canada., Traboulsee A; Department of Medicine (Neurology), University of British Columbia, Vancouver, B.C., Canada., Arbour N; Department of Neurosciences, Faculty of Medicine, Université de Montréal and Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada., Giuliani F; Department of Medicine (Neurology) and Neurosciences and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada., Lynd LD; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, B.C., Canada.; Centre for Advancing Health Outcomes, Providence Health Research Institute, Vancouver, B.C., Canada., Patten SB; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada., Prat A; Department of Neurosciences, Faculty of Medicine, Université de Montréal and Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada., Schabas A; Department of Medicine (Neurology), University of British Columbia, Vancouver, B.C., Canada., Smyth P; Department of Medicine (Neurology) and Neurosciences and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada., Tam R; Department of Radiology, University of British Columbia, Vancouver, B.C., Canada.; School of Biomedical Engineering, University of British Columbia, Vancouver, B.C., Canada., Zhang Y; Departments of Radiology & Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada., Graham SJ; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Hodaie M; Department of Surgery, University of Toronto, Toronto, Ontario, Canada., Feinstein A; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada., Kolind S; Department of Radiology, University of British Columbia, Vancouver, B.C., Canada.; Department of Medicine (Neurology), University of British Columbia, Vancouver, B.C., Canada.; Department of Physics and Astronomy, University of British Columbia, Vancouver, B.C., Canada., Schweizer TA; Department of Medicine (Neurology), University of Toronto, Toronto, Ontario, Canada.; Keenan Research Centre, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.; Department of Surgery, University of Toronto, Toronto, Ontario, Canada., Oh J; Department of Medicine (Neurology), University of Toronto, Toronto, Ontario, Canada.; BARLO Multiple Sclerosis Centre, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.; Keenan Research Centre, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada. |
| Corporate Authors: | CanProCo Study Group |
| Source: | Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2025 Sep; Vol. 12 (9), pp. 1794-1804. Date of Electronic Publication: 2025 Jun 29. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2328-9503 (Electronic) Linking ISSN: 23289503 NLM ISO Abbreviation: Ann Clin Transl Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2328-9503 |
|---|---|
| DOI: | 10.1002/acn3.70113 |
